FAIRFIELD, N.J., Jan. 15, 2012 /PRNewswire/ -- Aperture
Health, Inc. (OTC APRE.PK) announced that it has completed the
acquisition of Triad Therapeutics, Inc., ("Triad") a homecare
infusion therapy and nursing provider in New Jersey serving the tri-state area.
As a result, Triad has become a wholly owned subsidiary of Aperture
Health, Inc., and will remain as the operating company for the
combined business.
Triad provides specialized home healthcare services to patients
requiring intravenous therapy including antibiotics, pain
management, hydration, immunoglobulins, steroids, total nutritional
solutions, and IV catheter insertions and maintenance. The Company
provides a complete solution to patients including the preparation
and delivery of sterile compounded IV medications, supplies and
equipment, along with specialized nursing care and teaching of the
patient and/or caregivers on the administration of therapies as
prescribed by a physician.
Triad is a fully JCAHO accredited home IV therapy company,
achieving this "gold standard" status in 2007. The company has
built a well respected reputation in its industry for its therapy
expertise and commitment to care for its patient clients. The
company services clients throughout the states of New Jersey, New
York and Connecticut,
providing opportunity for organic growth. Triad's full time
marketing and sales personnel continuously represent the company in
the core services areas, growing and maintaining the company's
referral source base. Patient referrals are made from physicians,
hospitals, insurance companies, veterinarians and hospice care
providers that have established a professional rapport with
Triad.
All patient clients accepted to Triad's service have been
preapproved for care by the client's health insurance provider.
Triad maintains numerous managed care service provider contracts,
many of which are part of "closed networks," thus provide strong
barriers to entry in the industry.
The business of home infusion therapy is a mature industry with
multiple competitors. Triad markets its services to hospital
discharge planners, physicians, hospice providers, and veterinarian
hospitals. Triad vigorously and successfully competes for client
referrals by providing enhanced customer service and reliable cross
communication with the patients care givers, nurses, pharmacists
and physicians.
James Hennig, R.Ph, Chief
Executive Officer and Chairman of the Board of Directors commented,
"We are very pleased to become a U.S. publicly listed company which
will contribute to our market awareness and provide a platform for
the capital necessary for us to implement our growth strategy which
includes acquisitions and other joint ventures, as well as, organic
growth through new referral sources and product and service
enhancements."
Aperture Health, Inc. Reverse Merger Transaction:
Aperture Health Inc. (The Company), a Nevada Corporation, was
incorporated on Feb. 13th, 2001. On
July 18, 2011, Triad Therapeutics
Inc. merged into The Company via a reverse merger transaction as
consideration for all of the issued and outstanding shares of
Triad. The Triad shareholders received a 51% controlling interest
in The Company. On Sept. 13,
2011, The Company executed a 1:500 reverse stock split and
issued an additional 21 Million shares to Triad Shareholders. Triad
is the sole operating entity. Triad was incorporated in
Delaware in 2007.
The Company is in the process of updating their Pink Sheet
Disclosure and encourages readers to review such information as it
provides a more detailed status of the Company.
Safe Harbor
Certain statements in this news release are forward-looking,
including (without limitation) growing revenues and earnings,
expected results from current projects and attracting new
business. Undue reliance should not be placed on such
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties and other
unpredictable factors, many of which are beyond the Company's
control. The Company's actual results, performance and trends could
differ materially from those indicated or implied by such
statements as a result of various factors, including (without
limitation) the continued strengthening of Triad's selling and
marketing functions, continued customer satisfaction, contract
renewal, new product development, continued availability of capable
dedicated personnel, continued cost management, success and
availability of acquisitions, availability of financing and other
factors, as well as by factors applicable to most companies such as
general economic, competitive and other business and civil
conditions. Information regarding certain of those and other
risk factors and cautionary statements that could affect future
results, performance or trends is discussed in the Company's OTC
Disclosure Statement and unaudited management financials posted on
www.pinksheets.com. All of the Company's forward-looking
statements are expressly qualified by all such risk factors and
other cautionary statements. The information set forth herein
speaks only as of the date hereof.
SOURCE Aperture Health, Inc.